|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||5.33 - 5.86|
|52-week range||2.26 - 7.24|
|PE ratio (TTM)||N/A|
|Earnings date||14 Mar 2018 - 19 Mar 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7.50|
ChromaDex Corp. (NASDAQ:CDXC), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN™ in Singapore with its retail partner, Watsons. Singapore is the second Asian market for the U.S. made dietary supplement, after Hong Kong. With over 6,000 stores in 11 Asian and European markets, Watsons is the leading health and beauty retailer in Asia and Europe.
The Irvine, California-based company said it had profit of 4 cents per share. Losses, adjusted to account for discontinued operations, were 7 cents per share. The natural products company posted revenue ...